Key statistics
On Friday, Evogene Ltd (EVGN:NAQ) closed at 2.96, 29.54% above the 52 week low of 2.29 set on Sep 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.91 |
---|---|
High | 3.07 |
Low | 2.80 |
Bid | 2.70 |
Offer | 3.06 |
Previous close | 2.96 |
Average volume | 35.16k |
---|---|
Shares outstanding | 5.06m |
Free float | 4.97m |
P/E (TTM) | -- |
Market cap | 14.97m USD |
EPS (TTM) | -3.94 USD |
Data delayed at least 15 minutes, as of Oct 04 2024 20:59 BST.
More ▼
Press releases
- Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals
- Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement
- Evogene Reports Second Quarter 2024 Financial Results
- Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
- Evogene Schedules Second Quarter 2024 Financial Results Release
- Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil
- Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split
- ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants
More ▼